Caxton Associates (New York)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,670
| Closed | -$3.25M | – | 588 |
|
|
2024
Q3 | $3.25M | Sell |
3,670
-1,461
| -28% | -$1.29M | 0.12% | 58 |
|
|
2024
Q2 | $4.65M | Buy |
5,131
+428
| +9% | +$388K | 0.16% | 70 |
|
|
2024
Q1 | $3.66M | Buy |
+4,703
| New | +$3.66M | 0.21% | 56 |
|
|
2023
Q1 | – | Sell |
-211,000
| Closed | -$77.2M | – | 565 |
|
|
2022
Q4 | $77.2M | Buy |
+211,000
| New | +$77.2M | 5.15% | 4 |
|
|
2022
Q1 | – | Sell |
-3,143
| Closed | -$868K | – | 591 |
|
|
2021
Q4 | $868K | Sell |
3,143
-1,810
| -37% | -$500K | 0.09% | 123 |
|
|
2021
Q3 | $1.14M | Buy |
+4,953
| New | +$1.14M | 0.13% | 68 |
|
|
2020
Q4 | – | Sell |
-3,856
| Closed | -$571K | – | 220 |
|
|
2020
Q3 | $571K | Buy |
3,856
+1,556
| +68% | +$230K | 0.06% | 94 |
|
|
2020
Q2 | $378K | Sell |
2,300
-100
| -4% | -$16.4K | 0.03% | 177 |
|
|
2020
Q1 | $333K | Buy |
+2,400
| New | +$333K | 0.06% | 234 |
|
|
2019
Q4 | – | Sell |
-5,786
| Closed | -$647K | – | 475 |
|
|
2019
Q3 | $647K | Buy |
5,786
+2,096
| +57% | +$234K | 0.13% | 87 |
|
|
2019
Q2 | $409K | Buy |
+3,690
| New | +$409K | 0.05% | 209 |
|
|
2018
Q4 | – | Sell |
-2,333
| Closed | -$250K | – | 370 |
|
|
2018
Q3 | $250K | Buy |
+2,333
| New | +$250K | 0.02% | 305 |
|
|
2018
Q1 | – | Sell |
-16,228
| Closed | -$1.37M | – | 344 |
|
|
2017
Q4 | $1.37M | Buy |
+16,228
| New | +$1.37M | 0.07% | 121 |
|
|
2016
Q3 | – | Sell |
-8,890
| Closed | -$700K | – | 180 |
|
|
2016
Q2 | $700K | Sell |
8,890
-3,581
| -29% | -$282K | 0.02% | 139 |
|
|
2016
Q1 | $898K | Sell |
12,471
-11,182
| -47% | -$805K | 0.06% | 95 |
|
|
2015
Q4 | $1.99M | Buy |
23,653
+2,337
| +11% | +$197K | 0.32% | 43 |
|
|
2015
Q3 | $1.78M | Buy |
+21,316
| New | +$1.78M | 0.11% | 51 |
|